1. Structural chromosomal aberrations as potential risk markers in incident cancer patients.
- Author
-
Vodenkova S, Polivkova Z, Musak L, Smerhovsky Z, Zoubkova H, Sytarova S, Kavcova E, Halasova E, Vodickova L, Jiraskova K, Svoboda M, Ambrus M, Hemminki K, and Vodicka P
- Subjects
- Aged, Breast Neoplasms blood, Breast Neoplasms genetics, Case-Control Studies, Colorectal Neoplasms blood, Colorectal Neoplasms genetics, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Lung Neoplasms blood, Lung Neoplasms genetics, Lymphocytes cytology, Male, Middle Aged, Neoplasm Grading, Neoplasm Staging, Prognosis, Risk Factors, Biomarkers, Tumor genetics, Breast Neoplasms diagnosis, Chromosome Aberrations, Colorectal Neoplasms diagnosis, Lung Neoplasms diagnosis, Lymphocytes metabolism
- Abstract
Epidemiological prospective studies have shown that increased chromosomal aberrations (CAs) in peripheral blood lymphocytes may predict cancer risk. Here, we report CAs in newly diagnosed 101 colorectal, 87 lung and 158 breast cancer patients and corresponding healthy controls. Strong differences in distributions of aberrant cells (ACs), CAs, chromatid-type aberrations (CTAs) and chromosome-type aberrations (CSAs) were observed in lung and breast cancer patients as compared to healthy controls. In colorectal cancer (CRC) patients, only CTAs were significantly elevated. Binary logistic regression, adjusted for main confounders, indicates that all the analysed cytogenetic parameters along with smoking were significantly associated with breast and lung cancer risks. Significant differences in terminal deletions between breast cancer patients and corresponding female controls were recorded (0.39 vs. 0.18; P ≤ 0.05). We did not find any association of CAs with TNM (tumor nodus metastasis) stages or histopathological grade in either cancer type. CAs were neither associated with additional tumor characteristics-invasivity, ductal and lobular character, estrogene/progesterone receptors in breast tumors nor with non-small/small cell and bronchogenic/pulmonary types of lung tumors. Our study demonstrates that CAs serve as a predictive marker for breast and lung cancer, whereas only CTAs were elevated in incident CRC patients., (© The Author 2015. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF